Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NZMS (New Zealand Medical & Scientific) is a leading distributor of medical devices and diagnostic solutions, serving the healthcare and scientific communities in New Zealand and Australia since 1980. The company provides a comprehensive range of products across several specialized divisions, including medical, diagnostics, and diabetes management. In 2020, NZMS was acquired by Air Liquide Healthcare, a global leader in gases, technologies, and services for Industry and Health. Following this, in 2022, its diabetes distribution business was divested to Dexcom, a long-term partner of the company. NZMS remains a key partner for healthcare providers, offering advanced technology alongside clinical support and technical service. The company is headquartered in Auckland and maintains a strong presence in the Australasian medical technology market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NZMS.